483 Eli Lilly and Company Apr 2018

483 Eli Lilly and Company Apr 2018

Corrine Carter FDA, Myra Casey FDA$119.00 - Available Now

FDA investigators audited the Eli Lilly and Company - Indianapolis, IN, United States facility and issued inspectional observations (via FDA 483) on 23 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Apr 2018
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart